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Background: Based on the ethnomedicinal uses and the effective outcomes of natural products in various diseases,
this study was designed to evaluate Isodon rugosus as possible remedy in oxidative stress, alzheimer’s and other
neurodegenerative diseases. Acetylecholinestrase (AChE) and butyrylcholinesterase (BChE) inhibitory activities of
crude methanolic extract (Ir.Cr), resultant fractions (n-hexane (Ir.Hex), chloroform (Ir.Cf), ethyl acetate (Ir.EtAc),
aqueous (Ir.Aq)), flavonoids (Ir.Flv) and crude saponins (Ir.Sp) of I. rugosus were investigated using Ellman’s
spectrophotometric method. Antioxidant potential of I. rugosus was determined using DPPH, H2O2 and ABTS free
radicals scavenging assays. Total phenolic and flavonoids contents of plant extracts were determined and expressed
in mg GAE/g dry weight and mg RTE/g of dry sample respectively.
Results: Among different fractions Ir.Flv and Ir.Cf exhibited highest inhibitory activity against AChE (87.44 ± 0.51,
83.73 ± 0.64%) and BChE (82.53 ± 0.71, 88.55 ± 0.77%) enzymes at 1 mg/ml with IC50 values of 45, 50 for AChE
and 40, 70 μg/ml for BChE respectively. Activity of these fractions were comparable to galanthamine causing
96.00 ± 0.30 and 88.61 ± 0.43% inhibition of AChE and BChE at 1 mg/ml concentration with IC50 values of 20 and
47 μg/ml respectively. In antioxidant assays, Ir.Flv, Ir.Cf, and Ir.EtAc demonstrated highest radicals scavenging
activities in DPPH and H2O2 assays which were comparable to ascorbic acid. Ir.Flv was found most potent with IC50
of 19 and 24 μg/ml against DPPH and H2O2 radicals respectively. Whereas antioxidant activates of plant samples
against ABTS free radicals was moderate. Ir.Cf, Ir.EtAc and Ir.Cr showed high phenolic and flavonoid contents and
concentrations of these compounds in different fractions correlated well to their antioxidant and anticholinestrase
activities.
Conclusion: It may be inferred from the current investigations that the Ir.Sp, Ir.Flv and various fractions of I. rugosus
are good sources of anticholinesterase and antioxidant compounds. Different fractions can be subjected to activity
guided isolation of bioactive compounds effective in neurological disorders.
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Table 1 Total phenolics and total flavonoids of Ir.Cr and
subfractions of I. rugosus
Samples Total phenolics
(mg GAE/g of sample)
Total flavonoids
(mg RTE/g of sample)
Ir.Cr 65.51 ± 1.67 71.73 ± 0.69
Ir.Hex 41.38 ± 1.15 44.40 ± 2.76
Ir.Cf 82.60 ± 0.68 91.45 ± 1.12
Ir.EtAc 67.45 ± 0.83 68.46 ± 1.83
Ir.Aq 18.11 ± 2.25 27.12 ± 1.33
Each value in the table is represented as mean ± SEM (N = 3).
Abbreviations: Ir.Cr Crude methanolic extract, Ir.Hex n-hexane fraction,
Ir.Cf Chloroform fraction, Ir.EtAc Ethyl acetate fraction, Ir.Aq Aqueous fraction.
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Alzheimer's disease (AD) is a chronic neurodegenerative
disorder effecting more than twenty millions people glo-
bally and is the most common cause of dementia in elder
population [1,2]. AD is characterized by degeneration
of neurological function, presence of extra-neuronal amyl-
oid deposits, neuritic plaques, gradual deficits in various
neurotransmitters leading to decline in the levels of acetyl-
choline (ACh) and loss of cognitive abilities [1]. Inhibitors
of acetylecholinestrase (AChE) and butyrylcholinestrase
(BChE), key enzymes involved in the degradation of
neurotransmitter ACh, have been shown to function by
restoring the level of ACh in the synaptic region and thus
reinstate deficient cholinergic neurotransmission [3,4].
Since the discovery of cholinergic deficits in patients
suffering from neurological disorders, inhibition of these
enzymes is the main target in the treatment of AD, senile
dementia, Parkinsonism, ataxia and myasthenia gravis
[5,6]. Synthetic drugs used in the treatment of cognitive
dysfunction associated with AD and other diseases include
tacrine, donepezil and rivastigmine [7]. But these drugs
are associated with adverse effects including gastrointes-
tinal disturbances, hepatotoxicity and bioavailability prob-
lems [8,9], which necessitates the development of better
AChE and BChE inhibitors from natural resources i.e.
galantamine.
Reactive oxygen species (ROS) are produced during
aerobic respiration and other redox processes in the body.
These ROS can attack some important biomolecules like
enzymes, lipids, proteins, DNA and RNA leading to cel-
lular damage and plays a major role in aging process [10].
To counteract oxidative stress, human body has several
defense mechanisms including antioxidant enzymes and
non-enzymatic compounds. But excess of free radicals
make the organism unable to scavenge all ROS. These
ROS are implicated in the development of some chronic
diseases including cardiovascular diseases, cancer, diabetes,
nephritis, rheumatism and aging. Oxidative stress has been
reported to play a key role in the progression of neurode-
generative diseases like AD and Parkinson's disease [11,12].
Generally consumption of herbs, fruits and vegetables are
beneficial for health due to the presence of protective anti-
oxidant phyto-nutrients present in them [13,14]. Synthetic
antioxidant compounds including gallic acid esters, butyl-
ated hydroxy toluene (BHT), tertiary butylated hydroquin-
one and butylated hydroxy anisole (BHA) are associated
with severe adverse effects and hence their use is limited.
Consequently, there is need to discover new antioxidants
from natural sources [15]. In this regard antioxidant poten-
tial of numerous plants has been reported [16-19]. In anti-
oxidant compounds, flavonoids and phenolic compounds
are very important. These compounds has the ability to
scavenge free radicals effectively due to the presence of
hydroxyl groups and conjugated system [20].I. rugosus belongs to Labiateae, a family rich in species
containing huge number of pharmacologically active
compounds. The Isodon species are traditionally used as
anticancer, antimicrobial, insecticidal, antioxidants and
as anthelmintic [21-24]. I. rugosus is used traditionally in
the management of hypertension, rheumatism, tooth-
ache, and pyrexia [25]. Ethno-medicinally, this is used in
the treatment of skin diseases, ear, nose and throat infec-
tions and the treatment of intestinal disorders are also
reported [26]. In an effort to discover new sources which
can potentially be used in the treatment of oxidative
stress, AD and other neurological disorders, I. rugosus
was investigated for anticholinesterase and antioxidant
potentials.
Results
Total phenolic and flavonoid contents
Results of total phenolic and flavonoids contents in dif-
ferent fractions of I. rugosus are summarized in Table 1.
Results indicate that Ir.Cf, Ir.EtAc and Ir.Cr exhibited
high phenolic contents, i.e. 82.60 ± 0.68, 67.45 ± 0.83
and 65.51 ± 1.67 mg GAE/g of dry sample respectively.
Whereas, Ir.Cf, Ir.Cr and Ir.EtAc showed highest flavo-
noids content i.e. 91.45 ± 1.12, 71.73 ± 0.69 and 68.46 ±
1.83 mg RTE/g of sample respectively. Phenolic com-
pounds show greater antioxidant activity due to the
presence of hydroxyl groups and conjugated system in
their chemical strucutre [27,28]. Phenolic and flavonoid
contents in different fractions of plant correlated well to
the antioxidant activity.
Anticholinesterase assays
Results of AChE and BChE inhibitory potentials of
I. rugosus at various tested concentrations are summa-
rized in Table 2. In AChE inhibition assay, Ir.Flv, Ir.Cf
and Ir.Sp showed highest activity against AChE causing
87.44 ± 0.51, 83.73 ± 0.64 and 77.85 ± 0.56% inhibitions
at 1 mg/ml respectively. For these fractions IC50 values
were 45, 50 and 75 μg/ml respectively. Standard drug
galanthamine inhibited AChE enzyme by 96.00 ± 0.30%
at 1 mg/ml concentration with IC50 value of 20 μg/ml.







(μg/ml) (mean ± SEM) (μg/ml)
Ir.Sp 1000 77.85 ± 0.56***
75
69.48 ± 0.74***
210500 71.64 ± 0.75*** 62.62 ± 0.40***
250 62.58 ± 0.77*** 51.60 ± 0.46***
Ir.Cr 1000 71.75 ± 0.63***
140
68.68 ± 0.49***
145500 63.58 ± 0.70*** 61.72 ± 0.66***
250 56.61 ± 0.53*** 55.46 ± 0.63***
Ir.Hex 1000 64.79 ± 0.62***
630
62.61 ± 0.77***
380500 45.45 ± 0.49*** 54.60 ± 0.80***
250 43.75 ± 0.58*** 43.83 ± 0.56***
Ir.Cf 1000 83.73 ± 0.64***
50
88.55 ± 0.77ns
70500 79.47 ± 0.56*** 83.65 ± 0.77ns
250 67.81 ± 0.60*** 67.58 ± 0.74***
Ir.EtAc 1000 71.74 ± 0.61***
170
76.37 ± 0.68***
52500 69.68 ± 0.60*** 72.66 ± 0.78***
250 52.63 ± 0.76*** 63.62 ± 0.74***
Ir.Aq 1000 66.79 ± 0.63***
340
71.62 ± 0.74***
305500 59.67 ± 0.61*** 63.86 ± 0.60***
250 41.69 ± 0.77*** 44.48 ± 0.64***
Ir.Flv 1000 87.44 ± 0.51***
45
82.53 ± 0.71***
40500 73.76 ± 0.58*** 76.52 ± 0.68***
250 71.54 ± 0.50*** 68.51 ± 0.77***
Galanthamine 1000 96.00 ± 0.30
20
88.61 ± 0.43
47500 91.26 ± 1.27 83.25 ± 1.40
250 82.91 ± 1.30 74.03 ± 0.86
The data is represented as mean ± SEM, (N = 3). Values significantly different as compare to positive control, *P < 0.05, **P < 0.01, ***P < 0.001.
Abbreviations: Ir.Cr Crude methanolic extract, Ir.Hex n-hexane fraction, Ir.Cf Chloroform fraction, Ir.EtAc Ethyl acetate fraction, Ir.Aq Aqueous fraction, Ir.Flv Crude
flavonoids, Ir.Sp Crude Saponins.
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to the standard drug. AChE inhibition activity of all
other fractions was less than 60%. On the other hand,
Ir.Cf, Ir.Flv and Ir.EtAc were most effective fractions
against BChE enzyme, causing 88.55 ± 0.77, 82.53 ±
0.71 and 76.37 ± 0.68% inhibitions at 1 mg/ml concen-
tration respectively. Ir.Cf, Ir.Flv and Ir.EtAc were most
potent, presenting IC50 of 70, 40 and 52 μg/ml respec-
tively. BChE inhibitory activities of these fractions were
comparable to galanthamine result with percent inhi-
bition of 88.61 ± 0.43% at 1 mg/ml with IC50 value of
47 μg/ml.
Antioxidant assays
DPPH free radicals scavenging effect
Analysis of plant samples against DPPH free radicals re-
vealed that Ir.Flv, Ir.Sp, Ir.EtAc and Ir.Cf were most ef-
fective causing 81.1 ± 0.90, 76.36 ± 0.48, 74.53 ± 1.34 and71.63 ± 0.67% scavenging respectively at 1 mg/ml con-
centration. Median inhibitory concentrations (IC50) were
19, < 0.1, 22 and 28 μg/ml for Ir.Flv, Ir.Sp, Ir.EtAc and
Ir.Cf respectively as shown in Figure 1. Ascorbic acid
(Positive control) cause 85.71 ± 0.49% inhibition of DPPH
radicals at 1 mg/ml concentration and IC50 was 52 μg/ml.
Potency wise activity of Ir.Flv, Ir.Sp, Ir.EtAc and Ir.Cf was
better than ascorbic acid. Other fractions were effective in
concentration dependent manner. DPPH scavenging ac-
tivity for all the tested samples were in ascending order
of Ir.Flv > Ir.EtAc > Ir.Cf > Ir.Cr > Ir.Aq > Ir.Hex, shown
in Figure 2.
Hydrogen peroxide free radicals scavenging effect
In H2O2 free radicals scavenging activity, Ir.Flv, Ir.EtAc,
Ir.Sp, Ir.Cf and Ir.Cr showed highest activities causing
78.9 ± 0.41, 74.1 ± 0.67, 69.5 ± 0.67, 69.50 ± 0.67 and 64.4 ±
0.64% inhibition at 1 mg/ml concentration (Figure 3).
Figure 1 IC50 values of various samples against DPPH, H2O2 and ABTS free radicals. Abbreviations: Ir.Cr: Crude methanolic extract; Ir.Hex:
n-hexane fraction; Ir.Cf: Chloroform fraction; Ir.EtAc: Ethyl acetate fraction; Ir.Aq: Aqueous fraction; Ir.Flv: Crude flavonoids; Ir.Sp: Crude Saponins.
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respectively, as shown in Figure 1. Ascorbic acid inhibition
was 83.08 ± 0.47% at the same tested concentration with
IC50 24 μg/ml.
ABTS free radicals scavenging effect
In ABTS free radicals scavenging assay, Ir.Cr, Ir.Sp, Ir.
Hex, Ir.EtAc and Ir.Flv showed highest activity caus-
ing 79.35 ± 0.61, 74.89 ± 0.22, 74.1 ± 1.04, 64.99 ± 0.92






























Figure 2 Antioxidant potential of plant extracts using DPPH assay. Va
Values significantly different as compare to positive control *P < 0.05, **P <
Hex: n-hexane fraction; Ir.Cf: Chloroform fraction; Ir.EtAc: Ethyl acetate fracti
Saponins; A.acid: Ascorbic acid.concentration (Figure 4). For these fractions, the IC50
were 37, 70, 240 and 380 μg/ml respectively, as shown in
Figure 1. The ascorbic acid inhibition was 84.78 ± 0.40% at
1 mg/ml with IC50 of 50 μg/ml.
Correlation of total phenolic contents and various activities
Regression and correlation of total phenolic contents and
various assays have been summarized in Figure 5 (A, B, C,
D and E). The correlation coefficient (R2 = 0.742) obtained



















lues represent % radical scavenging (mean ± SEM) of three replicates.
0.01, ***P < 0.001. Abbreviations: Ir.Cr: Crude methanolic extract; Ir.












































Figure 3 Antioxidant potential of plant extracts using H2O2 assay. Values represent % radical scavenging (mean ± SEM) of three replicates.
Values significantly different as compare to positive control, *P < 0.05, **P < 0.01, ***P < 0.001. Abbreviations: Ir.Cr: Crude methanolic extract;
Ir.Hex: n-hexane fraction; Ir.Cf: Chloroform fraction; Ir.EtAc: Ethyl acetate fraction; Ir.Aq: Aqueous fraction; Ir.Flv: Crude flavonoids; Ir.Sp: Crude
Saponins; A.acid: Ascorbic acid.
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for H2O2 (y = 0.312x + 45.60) went parallel with the total
phenolic contents. Similarly, the correlation co-efficients
of ABTS and DPPH were calculated as 0.415 and 0.641
respectively. Furthermore, the regression line obtained
for AChE (y = 0.236x + 58.75) and BChE (y = 0.240x +
60.35) goes moderately parallel with the total phenolic





























Figure 4 Antioxidant potential of plant extracts using ABTS assay. Va
Values significantly different as compare to positive control, *P < 0.05, **P <
Ir.Hex: n-hexane fraction; Ir.Cf: Chloroform fraction; Ir.EtAc: Ethyl acetate frac
Saponins; A.acid: Ascorbic acid.Discussion
Antioxidant compounds are useful neuroprotective agents
in the therapy of early stages of Alzheimer’s disease (AD)
[29]. Though exact origin of AD is unknown, the dimi-
nution of neurotransmitters like ACh caused by the
enzymes AChE and BChE are clearly involved in the
etiology of this disease [30]. One treatment strategy is to
enhance cholinergic functions by the use of AChE and

















lues represent % radical scavenging (mean ± SEM) of three replicates.
0.01, ***P < 0.001. Abbreviations: Ir.Cr: Crude methanolic extract;
tion; Ir.Aq: Aqueous fraction; Ir.Flv: Crude flavonoids; Ir.Sp: Crude
Figure 5 Linear correlation for total phenolics Vs AChE (A), BChE (B), DPPH (C), H2O2 (D) and ABTS (E) activities.
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gard, use of selective inhibitors for AChE and BChE has
attracted particular attention in the treatment of the
Alzheimer-type dementia [31]. In recent times, BChE
received particular attention since it is a co-regulator of
cholinergic neurotransmission and its pharmacological ac-
tivity is increased in AD and associated with all neuro-
pathological lesions in this disorder [32]. Even though
selective inhibitors of BChE from synthetic origin, based
on quinazolinimines and lipoic acid have been reported
[33]. The search for more efficient and less expensive
natural substances is a mandatory research branch [29].
Use of AChE inhibitors like physostigmine or tacrine is
restricted due to limitations such as short half life and
serious side effects like hepatotoxicity. Alkylpyridiumpolymers, dehydroevodiamine (DHED) and carbamate
type AChE inhibitors have been recently reported, but due
to bioavailability problems and side effects, there is still
great interest in searching better AChE inhibitors from
natural sources [34].
Results of the current study revealed that Ir.Flv, Ir.Cf
and Ir.Sp possesses highest inhibitory potential against
AChE causing 87.44 ± 0.51, 83.73 ± 0.64 and 77.85 ± 0.56%
enzyme inhibitions respectively at 1 mg/ml concentration.
These fractions were most potent among others with IC50
values of 45, 50 and 75 μg/ml. AChE inhibitory activities
of these fractions were comparable to standard drug ga-
lanthamine, whose percent inhibition was 96.00 ± 0.30 at
the same tested concentration with IC50 of 20 μg/ml. In
BChE inhibition assay, Ir.Cf, Ir.Flv and Ir.EtAc were found
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0.78% enzyme inhibition at 1 mg/ml respectively. Median
inhibitory concentrations (IC50) for these fractions were
70, 40 and 52 μg/ml respectively. Activities of these frac-
tions were comparable to standard drug galanthamine at
the same tested concentration. Among different fractions,
Ir.Cf exhibited high phenolic (82.60 ± 0.68) and flavonoid
(91.45 ± 1.12) contents, which can be linked to its highest
enzyme inhibitory activities.
The use of antioxidants may slow the development of
Alzheimer’s disease (AD) and diminish neuronal dege-
neration [35,36]. Due to deteriorating effects of oxidative
stress on human health the interest in naturally occur-
ring antioxidant has been increased [37]. The flavonoids
are reported to possess strong BChE inhibitory potential
[38]. The age related brain performance can be improved
by the use of vegetables and fruits rich in flavonoids which
have the capability to neutralize the free radicals [39]. The
total phenolic and flavonoid contents can be correlated
with the antioxidant potential against free radicals which
can lead to cognitive aging and CNS disorders [40]. Phen-
olic acids have been reported as natural radical scavengers
in vegetables, fruits and herbs by several researchers [41].
The antioxidant potential of phenolics is attributed to
their redox properties which enables them to give hydro-
gen or quench the singlet oxygen [42].
The concentrations of the crude plant extracts that
inhibited the DPPH, H2O2 and ABTS radicals by 50%
(IC50) are presented in the Figure 1. In DPPH free radi-
cals scavenging assay, Ir.Sp, Ir.Flv, Ir.EtAc and Ir.Cf were
found most potent with IC50 of 0.1, 19, 22 and 28 μg/ml
respectively. In H2O2 scavenging assay, Ir.Flv, Ir.EtAc
and Ir.Cf proved IC50 of 24, 30 and 34 μg/ml respectively.
Likewise, in ABTS free radicals scavenging activity, Ir,Cr,
Ir.Aq and Ir.Sp exhibited IC50 of 37, 55 and 70 μg/ml re-
spectively. In Linear correlation of total phenolic contents
vs DPPH, H2O2 and ABTS radicals scavenging activities,
these exhibited correlation coefficient of R2 = 0.641, 0.742
and 0.415 respectively (Figure 5C, D and E). Concentra-
tions of phenolics in different fractions correlated well to
antioxidant and anticholinestrase activities. The current
investigations suggest that I. rugosus is a good source
of anticholinesterase and antioxidant compounds. The
fractions showing highest activities should be further
subjected to isolation of novel, cost effective and safer ac-
tive compounds useful in the treatment of neurological
disorders.
Conclusion
Based on the current investigations it may be concluded
that the Ir.Flv, Ir.Sp and Ir.Cf isolated from I. rugosus
exhibited anticholinesterase and antioxidant activities
comparable to that of standard drugs which can be attri-
buted to their high phenolic contents. The current studysuggests further investigations of I. rugosus for isolation,
purification and characterization of valuable bioactive
compounds for the treatment of various neurodegenera-
tive diseases.
Methods
Plant collection and extraction
The aerial parts of I. rugosus were collected from Dir
(U) Khyber Pakhtunkhwa, Pakistan in May 2013. The
plant was identified by plant taxonomist at the depart-
ment of Botany, Shaheed Benazir Bhutto University,
Sheringal Dir (U) KP, Pakistan. The plant specimen was
deposited at the herbarium of the same University with
voucher number (1016AZ). The plant material was
cleaned from dust with tap water and then with distilled
water till the complete removal of all the extra particles.
It was spread on a clean paper and shade dried for
23 days. The plant material was converted into coarse
powder with the help of a grinder. The powdered material
(11 kg) was soaked in 80% methanol for 15 days and was
filtered. The filtrated solution was concentrated under
reduced pressure using rotary evaporator (Heidolph
Laborota 4000, Schwabach, Germany) at 40°C. Finally, the
crude methanolic extract (900 g) was obtained.
Fractionation
The crude methanolic extract having weight of 900 g
was added to separating funnel and mixed with 500 mL
of n-hexane, chloroform and ethyl acetate and fraction-
ated by successive solvent-solvent extraction method
starting from the low polar solvent towards the high
polar solvent using method described previously [43]. Fi-
nally, Ir.Hex, Ir.Cf, Ir.EtAc and Ir.Aq obtained were 30 g,
45 g, 50 g and 180 g respectively.
Extraction of crude saponins
Crude saponins from Isodon rugosus were extracted by
adding 20 g of the plant sample in a conical flask having
100 mL of 20% ethanol. This mixture was heated on
water bath at 55°C for 4 h followed by filtration. The
residue obtained was extracted again with 200 mL of
20% ethanol and was added to the first collection.
Volume of solvent extract was reduced to 40 ml using
water bath to obtained greenish color residue. The resi-
due was transferred into a separating funnel and diethyl
ether (20 mL) was added to it. After vigorous shaking,
the separating funnel was put in a stand to get two
layers. The upper organic layer was discarded while the
lower aqueous layer obtained was diluted with 60 mL of
n-butanol. This combined n-butanol extract was washed
twice with 10 ml of 5% NaCl solution. The solution was
evaporated by keeping in water bath to obtain the dried
saponins [44].
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Harborne’s procedure was followed for the isolation of
crude flavonoids [45]. Plant sample having weight of 20 g
was taken in powdered form and heated in 200 ml of 2 M
HCl at 50°C under reflux for 30 minutes. It was allowed to
cold and then filtered using whatman No.42 filter paper.
The filtrate was treated with equal volume of ethyl acetate.
The flavonoids present in the extract were precipitated,
which was recovered with the help of weighed filter paper.
The weight of flavonoids obtained was 1.5 grams (7.5%).
Determination of total phenolic contents
The total phenolic contents was determined following
the procedure reported previously [46]. Briefly, 1 ml of
diluted extract was mixed with 9 ml of distilled water
followed by addition of 1 ml of Folin-Ciocalteu’s reagent
(FCR) with vigorous shaking. After 5 min, 10 ml of 7%
Na2CO3 solution was added to it and properly mixed.
The mixture was diluted to 25 ml with distilled water
and shaken properly. After 90 min, the absorbance was
measured by using UV spectrophotometer at 750 nm.
Gallic acid standard curve was used for the measure-
ment of total phenolic contents. The total phenolics
were expressed as milligrams of gallic acid equivalent
(mg GAE/g) per gram of dry sample.
Determination of total flavonoids contents
Total flavonoid contents of Isodon rugosus were deter-
mined using procedure previously described [47]. Briefly,
0.3 ml of plant sample solution, 0.15 ml NaNO2 (0.5 M),
3.4 ml methanol (30%) and 0.15 ml AlCl3.6H2O (0.3 M)
were mixed and added to a 10 ml test tube. After 5 min,
1 ml of NaOH (1.0 M) was added to it. The absorbance of
the mixture was measured by using UV spectrophotom-
eter at 506 nm. For the determination of total flavonoids,
standard Rutin solution curve (0 to 100 mg/l) was used.
The total flavonoid contents were expressed as milligram
of rutin equivalent per gram of dry sample (mg RTE/g).
Chemicals and drugs
Potassium phosphate buffer (pH 8.0), Galantamine from
Lycoris Sp. (Sigma-Aldrich France), Butyrylthiocholin
iodide (Sigma-Aldrich Switzerland), Acetylthiocholine
Iodide (Sigma-Aldrich UK), 5,5-dithio-bis-nitrobenzoic
acid (DTNB) (Sigma-Aldrich Germany), Electric eel
acetylcholinesterase (type-VI-S, Sigma-Aldrich USA)
and Aquine butyrylcholinesterase (Sigma-Aldrich USA)
were used in enzyme inhibition assays. For antioxidant
assays, DPPH (Sigma Aldrich CHEMIE GmbH USA),
H2O2 (Riedel-de Haen Germany) and ABTS (Sigma-
Aldrich Germany) were used. All solvents used in the
assays were of analytical grades purchased from Sigma-
Aldrich.Anticholinesterase assays
In this method, plant samples were evaluated spectro-
photometrically for AChE and BChE inhibition potentials
using acetylthiocholine iodide and Butyrylthiocholine iod-
ide as substrates, respectively following Ellman assay [48].
In this method, 205 μl of plant samples (125–1000 μg/ml)
were added to the cuvette contained BChE (0.01 U/ml)
and 5 μl of AChE (0.03 U/ml). DTNB (5 μl) was added to
the mixture and incubated for 15 min in a water bath
having temperature of 30°C. To start the reaction added
5 μl substrates to the mixture. Absorbance was measured
using double beam Spectrophotometer at wavelength of
412 nm for 4 min.
The reaction between thiocholines and DTNB was
indicated by the formation of 5-thio-2-nitrobenzoate
anion, which showed by yellow color appearance. White
assay was carried out to check the hydrolysis of substrate
contained no enzymes and plant samples. The reaction
mixture containing without plant sample was taken as
control. Percent enzyme activity and percent inhibition
were calculated as follows;
V ¼ ΔAbs
Δt
% enzyme activity ¼ V
Vmax
 100
% enzyme inhibition ¼ 100−% enzyme activity
(Where V indicates the rate of reaction in the pre-
sence of inhibitor and Vmax is the rate of reaction with-
out inhibitor).
Antioxidant assays
DPPH free radicals scavenging activity
For DPPH free radicals scavenging activity the method
of Brand-Williams et al. was followed with some modi-
fications [49]. DPPH (24 mg) was dissolved in 100 ml
of methanol to prepare DPPH solution. The stock solu-
tions of plant samples were prepared in methanol hav-
ing concentrations of 1 mg/ml and then diluted to the
concentrations 1000, 500, 250 μg/ml. DPPH and sam-
ple solutions were mixed in a ratio of 1:1 and were in-
cubated at 23°C for 30 min. Finally, absorbance was
measured at 517 nm using UV spectrophotometer
(Thermo electron corporation USA). Ascorbic acid was
used as positive control. Percent radical scavenging ac-
tivity was measured using the following equation;
Scavenging effect % ¼ control absorbance−sample absorbance
control absorbance
 100
Hydrogen peroxide free radicals scavenging activity
The plant samples were investigated for hydrogen peroxide
free radical scavenging potential following the procedure of
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oxide was prepared in 50 mmol phosphate buffer having
pH of 7.4. Various plant samples (0.1 ml) were taken in
test tubes followed by addition of 50 mmol phosphate
buffer to make the final volume 0.4 ml. Hydrogen per-
oxide (0.6 ml) was added to the test tube and kept for
10 min. Absorbance was measured spectrophotometrically
at 230 nm against the blank. The hydrogen peroxide scav-
enging activity was calculated using the following equation;
Hydrogen peroxide scavenging activity ¼ 1−sample absorbance
control absorbance
 100
ABTS free radicals scavenging activity
Antioxidant potentials of Ir.Cr, Ir.Hex, Ir.EtAc, Ir.Cf, Ir.
Aq, Ir.Flv and Ir.Sp were investigated using the free
radicals of 2, 2-azinobis [3-ethylbenzthiazoline]-6-sulfonic
acid (ABTS) [51]. ABTS (7 mmol) and potassium persul-
fate (2.45 mmol) solutions were prepared and thoroughly
mixed. For production of free radicals, the solution was
kept in the dark for 8 h at room temperature. Prior to
use, ABTS solution was diluted with Phosphate buffer
(0.01 M), pH 7.4. The absorbance of ABTS solution was
adjusted to 0.7 at 745 nm by the addition of 50% metha-
nol. Radical scavenging ability of the fractions was ana-
lyzed by mixing 300 μl of each test sample with 3.0 ml of
ABTS solution in a cuvette. The absorbance of the solu-
tion was measured using a double beam spectrophotom-
eter for 6 min. Ascorbic acid was used as positive control.
The experiment was repeated three times and percent
ABTS scavenging activity was calculated as follows;




Each experiment was performed in three replicates and
values were expressed as mean ± SEM. One way ANOVA
followed by multiple comparison Dunnett's test was used
for the comparison of positive control with the test
groups. The P values less than 0.05 were considered as
statistically significant. IC50 values were calculated by a
linear regression analysis among the percent inhibition
against the extract concentrations via Excel program.
Regression and linear correlation
Regression (y) and linear correlation (R2) for phenolic
contents and various activities (anticholinesterase and an-
tioxidants) were determined using Microsoft Excel 2007.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AZ and SA carried out experimental work, data collection and literature
search under the supervision of AS. FU helped as co-supervision of the researchwork. MA drafted the manuscript for publication. AS make the final version of
publication. All the authors have read and approved the final manuscript
for publication.
Acknowledgements
The authors are grateful to the Department of Pharmacy for the kind
provision of research laboratories for conduction of these activities. We are
also thankful to Dr. Ali Hazrat, Department of Botany, SBBU, Sheringal, Dir
Upper, Pakistan for identification of plant.
Funding
This research received no specific grant from any funding agency in the
public, commercial, or not-for-profit sectors.
Received: 8 September 2014 Accepted: 18 December 2014
Published: 26 December 2014
References
1. Kamal MA, Al-Jafari AA, Yu Q-S, Greig NH: Kinetic analysis of the inhibition
of human butyrylcholinesterase with cymserine. Biochim Biophys Acta
BBA-Gen Subj 2006, 1760(2):200–206.
2. Ellis JM: Cholinesterase inhibitors in the treatment of dementia. J Am
Osteopath Assoc 2005, 105:145–158.
3. Giacobini E: Cholinesterase inhibitors for Alzheimer's disease therapy:
from tacrine to future applications. Neurochem Int 1998, 32:413–419.
4. Krall W, Sramek J, Cutler N: Cholinesterase inhibitors: a therapeutic
strategy for Alzheimer's disease. Ann Pharmacother 1999, 33:441–450.
5. Rahman A, Choudhary M: Bioactive natural products as a potential source
of new pharmacophores a theory of memory. Pure Appl Chem 2001,
73:555–560.
6. Brenner G: Pharmacology. Philadelphia: WB Saunders Company; 2000.
7. Oh M, Houghton P, Whang W, Cho J: Screening of Korean herbal
medicines used to improve cognitive function for anti-cholinesterase
activity. Phytomedicine 2004, 11:544–548.
8. Schulz V: Ginkgo extract or cholinesterase inhibitors in patients with
dementia: what clinical trial and guidelines fail to consider. Phytomedicine
2003, 10:74–79.
9. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW: Hepatotoxic
effects of tacrine administration in patients with Alzheimer's disease.
Jama 1994, 271:992–998.
10. Zhu X, Raina A, Lee H, Casadesus G, Smith M, Perry G: Oxidative stress
signaling in Alzheimer's disease. Brain Res 2004, 1000:32–39.
11. Lobo V, Patil A, Phatak A, Chandra N: Free radicals, antioxidants and
functional foods: impact on human health. Pharmacogn Rev 2010,
4(8):118–126.
12. Erejuwa O, Sulaiman SA, Wahab MS: Honey: a novel antioxidant. Molecules
2012, 17:4400–4423.
13. Zambonin L, Caliceti C, Sega F, Fiorentini D, Hrelia S, Landi L: Dietary
phenolic acids act as effective antioxidants in membrane models and in
cultured cells, exhibiting proapoptotic effects in leukaemia cells. Oxid
Med Cell Longev 2012, 2012:1–12.
14. Gordon A, Cruz A, Cabral L, Cordeiro de Freitas S, Taxi C, Donangelo C:
MChemical characterization and evaluation of antioxidant properties of
Acai fruits (Euterpe oleraceae Mart.) during ripening. Food Chem 2012,
133:256–263.
15. Barlow S: Toxicological aspects of antioxidants used as food additives.
In Food Antioxidants. Edited by Hudson BJF. London: Elsevier;
1990:253–307.
16. Zia-Ul-Haq M, Riaz M, De Feo V, Jaafar HZ, Moga M: Rubus fruticosus L.:
constituents, biological activities and health related uses. Molecules 2014,
19(8):10998–11029.
17. Shah SM, Ayaz M, Khan A-u, Ullah F, Iqbal H, Hussain S: 1, 1-Diphenyl,
2-picrylhydrazyl free radical scavenging, bactericidal, fungicidal and
leishmanicidal properties of Teucrium stocksianum. Toxicol Ind Health
2013, doi:10.1177/0748233713487250.
18. Kil HY, Seong ES, Ghimire BK, Chung I-M, Kwon SS, Goh EJ, Heo K, Kim MJ,
Lim JD, Lee D: Antioxidant and antimicrobial activities of crude sorghum
extract. Food Chem 2009, 115:1234–1239.
19. Ayaz M, Junaid M, Ahmed J, Ullah F, Sadiq A, Ahmad S, Imran M: Phenolic
contents, antioxidant and anticholinesterase potentials of crude extract,
Zeb et al. Biological Research 2014, 47:76 Page 10 of 10
http://www.biolres.com/content/47/1/76subsequent fractions and crude saponins from Polygonum hydropiper L.
BMC Complement Altern Med 2014, 14:145.
20. Shahidi F, Wanasundara P: Phenolic antioxidants. Crit Rev Food Sci Nutr
1992, 32:67–103.
21. Fujita E, Node M: Diterpenoids of Rabdosia species. In Fortschritte der
Chemie organischer Naturstoffe/Progress in the Chemistry of Organic Natural
Products. Vienna: Springer; 1984:77–157.
22. Faizul H, Habib A, Mukhtar A: Traditional uses of medicinal plants of
Nandiar Khuwarr catchment (District Battagram), Pakistan. J Med Plants
Res 2011, 5(1):39–48.
23. Collins M, Charles H: Antimicrobial activity of Carnosol and Ursolic acid:
two anti-oxidant constituents of Rosmarinus officinalis L. Food Microbiol
1987, 4:311–315.
24. Wojdyło A, Oszmiański J, Czemerys R: Antioxidant activity and phenolic
compounds in 32 selected herbs. Food Chem 2007, 105:940–949.
25. Khan SW, Khatoon S: Ethnobotanical studies on useful trees and shrubs
of Haramosh and Bugrote valleys, in Gilgit northern areas of Pakistan.
Pak J Bot 2007, 39(3):699–710.
26. Adnan M, Begum S, Khan AL, Tareen AM, Lee I-J: Medicinal plants and
their uses in selected temperate zones of Pakistani Hindukush-Himalaya.
J Med Plants Res 2012, 6:4113–4127.
27. Duh P-D, Tu Y-Y, Yen G-C: Antioxidant activity of water extract of Harng
Jyur (Chrysanthemum morifolium Ramat). LWT-Food Sci Technol 1999,
32:269–277.
28. Hatano T, Edamatsu R, Hiramatsu M, Mori A, Fujita Y, Yasuhara T, Yoshida T,
Okuda T: Effects of the interaction of tannins with co-existing substances.
VI: effects of tannins and related polyphenols on superoxide anion
radical, and on 1, 1-diphenyl-2-picryl hydrazyl radical. Chem Pharm Bull
1989, 37:2016–2021.
29. Decker M, Kraus B, Heilmann J: Design, synthesis and pharmacological
evaluation of hybrid molecules out of quinazolinimines and lipoic acid
lead to highly potent and selective butyrylcholinesterase inhibitors with
antioxidant properties. Bioorg Med Chem 2008, 16:4252–4261.
30. Piazzi L, Belluti F, Bisi A, Gobbi S, Rizzo S, Bartolini M, Andrisano V,
Recanatini M, Rampa A: Cholinesterase inhibitors: SAR and enzyme
inhibitory activity of 3-[omega-(benzylmethylamino) alkoxy] xanthen-9-
ones. Bioorg Med Chem 2006, 15(1):575–585.
31. Kim W-G, Cho K-M, Lee C-K, Yoo I-D: Terreulactone A, a novel meroterpenoid
with anti-acetylcholinesterase activity from Aspergillus terreus. Tetrahedron
Lett 2002, 43:3197–3198.
32. Darvesh S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh
R, Martin E: Selective reversible inhibition of human butyrylcholinesterase
by aryl amide derivatives of phenothiazine. Bioorg Med Chem 2007,
15(19):6367–6378.
33. Lobo V, Patil A, Phatak A, Chandra N: Free radicals, antioxidants and
functional foods: Impact on human health. Pharmacog Rev 2010, 4:118.
34. Schneider LS: New therapeutic approaches to Alzheimer's disease. J Clin
Psychiatry 1995, 57:30–36.
35. Choudhary MI: Bioactive natural products as a potential source of new
pharmacophores. A theory of memory. Pure Appl Chem 2001, 73:555–560.
36. Howes MJR, Perry NS, Houghton PJ: Plants with traditional uses and
activities, relevant to the management of Alzheimer's disease and other
cognitive disorders. Phytother Res 2003, 17:1–18.
37. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L: Dietary
polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005,
45:287–306.
38. Noor A-t, Fatima I, Ahmad I, Malik A, Afza N, Iqbal L, Latif M, Khan SB:
Leufolins A and B, potent butyrylcholinesterase-inhibiting flavonoid
glucosides from Leucas urticifolia. Molecules 2007, 12:1447–1454.
39. Youdim KA, Shukitt-Hale B, Joseph JA: Flavonoids and the brain: interactions
at the blood–brain barrier and their physiological effects on the central
nervous system. Free Radic Biol Med 2004, 37:1683–1693.
40. Golden TR, Hinerfeld DA, Melov S: Oxidative stress and aging: beyond
correlation. Aging Cell 2002, 1:117–123.
41. Larson RA: The antioxidants of higher plants. Phytochemistry 1988, 27:969–978.
42. Rice-evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB: The relative
antioxidant activities of plant-derived polyphenolic flavonoids. Free Rad
Res 1995, 22:375–383.
43. Ayaz M, Junaid M, Subhan F, Ullah F, Sadiq A, Ahmad S, Imran M, Kamal Z,
Hussain S, Shah SM: Heavy metals analysis, phytochemical, phytotoxic
and anthelmintic investigations of crude methanolic extract, subsequentfractions and crude saponins from Polygonum hydropiper L. BMC
Complement Altern Med 2014, 14:465.
44. Zeb A, Sadiq A, Ullah F, Ahmad S, Ayaz M: Phytochemical and
toxicological investigations of crude methanolic extracts, subsequent
fractions and crude saponins of Isodon rugosus. Biol Res 2014, 47(1):57.
45. Harborne A: Phytochemical methods a guide to modern techniques of plant
analysis. London: Springer; 1998.
46. Kim D-O, Jeong SW, Lee CY: Antioxidant capacity of phenolic phytochemicals
from various cultivars of plums. Food Chem 2003, 81(3):321–326.
47. Park H-H, Lee S, Son H-Y, Park S-B, Kim M-S, Choi E-J, Singh TS, Ha J-H,
Lee M-G, Kim J-E: Flavonoids inhibit histamine release and expression of
proinflammatory cytokines in mast cells. Arch Pharm Res 2008,
31(10):1303–1311.
48. Classics Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and
rapid colorimetric determination of acetylcholinesterase activity. Biochem
Pharmacol 1961, 7:88–95.
49. Brand-Williams W, Cuvelier M, Berset C: Use of a free radical method to
evaluate antioxidant activity. LWT-Food Sci Technol 1995, 28:25–30.
50. Ruch RJ, Cheng S-J, Klaunig JE: Prevention of cytotoxicity and inhibition of
intercellular communication by antioxidant catechins isolated from
Chinese green tea. Carcinogenesis 1989, 10:1003–1008.
51. Re R, Pellegrini N, Proteggente A, Pannala A, Yong M, Rice-Evas C:
Antioxidant activity applying an improved FBTS radical cation
decolorization assay. Free Rad Biol Med 1999, 26(9/10):1231–1237.
doi:10.1186/0717-6287-47-76
Cite this article as: Zeb et al.: Investigations of anticholinestrase and
antioxidant potentials of methanolic extract, subsequent fractions,
crude saponins and flavonoids isolated from Isodon rugosus. Biological
Research 2014 47:76.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
